Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Annual Use Limitations For Prilosec 1 Should Appear In Labeling – NDAC/GDAC

This article was originally published in The Tan Sheet

Executive Summary

Labeling for Prilosec 1 should advise patients not to take the product for more than two or three 14-day courses per year, the Nonprescription and Gastrointestinal Drugs Advisory Committees said

You may also be interested in...



Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes

FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen

Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes

FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen

Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes

FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen

Related Content

Topics

UsernamePublicRestriction

Register

PS094191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel